Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 9/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 9/20 | 0.47 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 10/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 9/20 | 0.46 |
| ▸ | MAPT | P10636 | 8/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 7/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 7/20 | 0.46 |
| ▸ | TP53 | P04637 | 6/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 6/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 5/20 | 0.46 |
| ▸ | POLH | Q9Y253 | 5/20 | 0.46 |
| ▸ | HPGD | P15428 | 5/20 | 0.46 |
| ▸ | ABCB1 | P08183 | 5/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.46 |
| ▸ | APP | P05067 | 4/20 | 0.46 |
| ▸ | CSNK2A2 | P19784 | 4/20 | 0.46 |
| ▸ | XDH | P47989 | 4/20 | 0.46 |
| ▸ | DAPK1 | P53355 | 4/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31260540 | 0.84 | MEN1 (0.41) | MEN1KMT2AHSP90AA1KDM4ECYP3A4 | |
| SCHEMBL3367046 | 0.81 | MEN1 (0.50) | MEN1KMT2AHSP90AA1KDM4ECYP3A4 | |
| SCHEMBL2565483 | 0.69 | CYP3A4 (0.78) | MEN1KMT2AHSP90AA1KDM4ECYP3A4 | |
| SCHEMBL30684642 | 0.69 | CYP3A4 (0.78) | MEN1KMT2AHSP90AA1KDM4ECYP3A4 | |
| SCHEMBL4104591 | 0.66 | MEN1 (0.64) | MEN1KMT2AHSP90AA1KDM4ECYP3A4 | |
| SCHEMBL5040391 | 0.64 | MEN1 (0.70) | MEN1KMT2AHSP90AA1KDM4ECYP3A4 | |
| SCHEMBL12940979 | 0.64 | MEN1 (1.00) | MEN1KMT2AHSP90AA1KDM4ECYP3A4 | |
| SCHEMBL22142507 | 0.64 | MEN1 (0.61) | MEN1KMT2AHSP90AA1KDM4ECYP3A4 | |
| Kaempferol SCHEMBL1259228 | 0.64 | MEN1 (1.00) | MEN1KMT2AKDM4ECYP3A4MAPT | |
| Kaempferol SCHEMBL30655455 | 0.64 | MEN1 (1.00) | MEN1KMT2AKDM4ECYP3A4MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1956923-A1 | ISOFLAVONE COMPOSITIONS FOR REDUCING ACCUMULATION OF BODY FAT IN MALE MAMMALS, AND METHODS FOR THEIR USE | NESTEC S.A. (CH) | 2008-08-20 | — | — | EP | claimed |
| WO-2007051629-A1 | ISOFLAVONE COMPOSITIONS FOR REDUCING ACCUMULATION OF BODY FAT IN MALE MAMMALS, AND METHODS FOR THEIR USE | NESTEC S.A. (CH) | 2007-05-10 | — | — | WO | claimed |
| CN-110087661-B | Aglycone production promoter | 森永乳业株式会社 | 2022-10-21 | — | — | CN | disclosed |
| US-11160755-B2 | Amphiphilic polymer | LG CHEM, LTD. (KR) | 2021-11-02 | — | — | US | disclosed |
| CN-109312035-B | Amphiphilic polymers | 株式会社LG化学 | 2021-07-30 | — | — | CN | disclosed |
| US-20210205344-A1 | COMPOSITION CONTAINING FLAVONOID-CYCLODEXTRIN CLATHRATE COMPOUND | TAIYO KAGAKU CO., LTD. (JP) | 2021-07-08 | — | — | US | disclosed |
| US-11034786-B2 | Amphiphilic triblock polymer | LG CHEM, LTD. (KR) | 2021-06-15 | — | — | US | disclosed |
| CN-109153758-B | Amphiphilic triblock polymers | 株式会社LG化学 | 2021-04-27 | — | — | CN | disclosed |
| EP-3805399-A1 | COMPOSITION CONTAINING FLAVONOID-CYCLODEXTRIN CLATHRATE COMPOUND | Taiyo Kagaku Co., Ltd. (JP) | 2021-04-14 | — | — | EP | disclosed |
| CN-107207736-B | Amphiphilic polymers | 株式会社LG化学 | 2021-04-02 | — | — | CN | disclosed |
| CN-112538439-A | Lactobacillus plantarum and application thereof in preparing plant coagulated yoghurt and improving intestinal bacterial facies | 欧斐生 | 2021-03-23 | — | — | CN | disclosed |
| EP-3205688-A1 | AMPHIPHILIC POLYMER | LG Chem, Ltd. (KR) | 2017-08-16 | — | — | EP | disclosed |
| US-20170143628-A1 | AMPHIPHILIC POLYMER | LG CHEM, LTD. (KR) | 2017-05-25 | — | — | US | disclosed |
| EP-2208422-B1 | Compositions and methods for reducing or preventing obesity | NESTEC SA (CH) | 2015-11-25 | — | — | EP | disclosed |
| EP-1750523-B1 | COMPOSITIONS AND METHODS FOR REDUCING OR PREVENTING OBESITY | NESTEC SA (CH) | 2010-07-21 | — | — | EP | disclosed |
| EP-2208422-A1 | Compositions and methods for reducing or preventing obesity | Nestec S.A. (CH) | 2010-07-21 | — | — | EP | disclosed |
| EP-1988891-A2 | COMPOSITIONS AND METHODS FOR INDUCING BONE GROWTH AND INHIBITING BONE LOSS | NESTEC S.A. (CH) | 2008-11-12 | — | — | EP | disclosed |
| WO-2007100671-A2 | COMPOSITIONS AND METHODS FOR INDUCING BONE GROWTH AND INHIBITING BONE LOSS | NESTEC S.A. (CH) | 2007-09-07 | — | — | WO | disclosed |
| EP-1750523-A1 | COMPOSITIONS AND METHODS FOR REDUCING OR PREVENTING OBESITY | Nestec S.A. (CH) | 2007-02-14 | — | — | EP | disclosed |
| WO-2005089567-A1 | COMPOSITIONS AND METHODS FOR REDUCING OR PREVENTING OBESITY | NESTEC S.A. (CH) | 2005-09-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11034786-B2 | Amphiphilic triblock polymer | ABCB4, LIPA, CETP | MEN1 3864/4885KMT2A 4752/4885HSP90AA1 2210/4885 |
| US-11160755-B2 | Amphiphilic polymer | LIPA, CETP, ABCB4 | MEN1 2999/4885KMT2A 4385/4885HSP90AA1 2134/4885 |
| US-20170143628-A1 | AMPHIPHILIC POLYMER | ABCB11, LIPA, SLC10A2 | MEN1 2007/4885KMT2A 4815/4885HSP90AA1 3679/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.